What's New

Latest News

FDA strengthens canagliflozin and dapagliflozin kidney warnings

FDA has strengthened existing warnings about the risk of acute kidney injury associated with canagliflozin and dapagliflozin

FDA approves canagliflozin/metformin combo as first-line therapy

The fixed-dose combination can be prescribed in type 2 diabetes patients why may benefit from dual therapy

FDA adds warning about amputation risk with canagliflozin

The SGLT2 inhibitor has been associated with a two-fold risk for leg and foot amputations in a clinical trial

FDA: Metformin safe for some patients with renal impairment

FDA has expanded the labeling of diabetes medications that contain metformin to include patients with mild to moderate renal impairment

Sponsored Infosites 

Diabetes Infographics

 Infographics Thumb new 

Downloadable infographics including the International Diabetes Federation Diabetes Atlas, Hypoglycemia in the US from AADE, and National Diabetes Statistics reports.

Click here.


Diabetes News & Information


Get more diabetes headlines. 

NDEI.org: Diabetes Education for Healthcare Professionals

NDEI.org is a premier online destination for diabetes education and information for HCPs. Since 1996, we have partnered with preeminent thought leaders to provide diabetes education on issues spanning the diabetes continuum. Award-winning content:

  • Slide library with 1,500+ downloadable slides
  • On-demand programs, including interactive case studies and webcasts
  • Diabetes guidelines resources
  • Expert commentaries on diabetes data
  • Patient education handouts
  • And more!

Registration is free and unlocks premium content offerings and incentives. Sign up here.

NDEI.org is the official website of The National Diabetes Education Initiative® (NDEI®).

Partner Site